CSIMarket
 


Amgen Inc   (AMGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

AMGN's EPS from Cont. Operations Growth by Quarter and Year

Amgen Inc 's EPS from Cont. Operations results by quarter and year




AMGN EPS from Cont. Operations (in $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter December - 2.88 3.05 -5.88
III Quarter September - 3.29 2.88 2.78
II Quarter June - 3.59 3.50 2.93
I Quarter March 3.09 3.20 3.27 2.81
FY   3.09 12.96 12.70 2.64



AMGN EPS from Cont. Operations first quarter 2020 Y/Y Growth Comment
Amgen Inc reported decrease in EPS from Cont. Operations in the first quarter by -3.44% to $ 3.09 , from the same quarter in 2019.
The decrease in the first quarter Amgen Inc 's EPS from Cont. Operations compares unfavorably to the Company's average EPS from Cont. Operations growth of 6.09%.

Looking into first quarter results within Biotechnology & Drugs industry 11 other companies have achieved higher EPS from Cont. Operations growth. While Amgen Inc ' s EPS from Cont. Operations decline of -3.44% ranks overall at the positon no. 716 in the first quarter.




AMGN EPS from Cont. Operations ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter December - -5.57 % - -
III Quarter September - 14.24 % 3.6 % 2.96 %
II Quarter June - 2.57 % 19.45 % 17.67 %
I Quarter March -3.44 % -2.14 % 16.37 % 11.51 %
FY   - 2.05 % 381.06 % -74.42 %

Financial Statements
Amgen Inc 's first quarter 2020 EPS from Cont. Operations $ 3.09 AMGN's Income Statement
Amgen Inc 's first quarter 2019 EPS from Cont. Operations $ 3.20 Quarterly AMGN's Income Statement
New: More AMGN's historic EPS from Cont. Operations Growth >>


AMGN EPS from Cont. Operations (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter December - -12.46 % 5.9 % -
III Quarter September - -8.36 % -17.71 % -5.12 %
II Quarter June - 12.19 % 7.03 % 4.27 %
I Quarter March 7.29 % 4.92 % - 7.66 %
FY (Year on Year)   - 2.05 % 381.06 % -74.42 %




EPS from Cont. Operations first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #12
Healthcare Sector #70
Overall #716

EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
236.99 % 6.09 % -76.3 %
(Dec 31 2018)   (Dec 31 2017)
EPS from Cont. Operations first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #12
Healthcare Sector #70
Overall #716
EPS from Cont. Operations Y/Y Growth Statistics
High Average Low
236.99 % 6.09 % -76.3 %
(Dec 31 2018)   (Dec 31 2017)

EPS from Cont. Operations by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Amgen Inc 's Q/Q EPS from Cont. Operations Growth


EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
9300 % 157.42 % -98.8 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q EPS from Cont. Operations Comment
Amgen Inc achieved in the I. Quarter 2020 below company average EPS from Cont. Operations increase of 7.29% quarter on quarter, to $ 3.09 .

I. Quarter 2020 Amgen Inc 's results seem to be contradictory, although below the average, yet it demonstrates absolute acceleration measured to the 4.92% in the I. Quarter a year ago

Within Biotechnology & Drugs industry 6 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Amgen Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 445.


EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #7
Healthcare Sector #40
Overall #445
EPS from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #7
Healthcare Sector #40
Overall #445
EPS from Cont. Operations Q/Q Growth Statistics
High Average Low
9300 % 157.42 % -98.8 %
(Sep. 30, 2006)  


AMGN's I. Quarter Q/Q EPS from Cont. Operations Comment
Amgen Inc achieved in the I. Quarter 2020 below company average EPS from Cont. Operations increase of 7.29% quarter on quarter, to $ 3.09 .

Even if the I. Quarter 2020 Amgen Inc 's performance was below the regular , that has been still encouraging story, as the current improvement, transcends the 4.92% surge in the I. Quarter a year ago

Within Biotechnology & Drugs industry 6 other companies have achieved higher EPS from Cont. Operations quarter on quarter growth. While Amgen Inc 's EPS from Cont. Operations growth quarter on quarter, overall rank is 445.


Amgen Inc 's 12 Months EPS from Cont. Operations Growth Year on Year


EPS from Cont. Operations TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative EPS from Cont. Operations 12 Months Ending $ 12.85 $ 12.96 $ 13.13 $ 12.72 $ 12.63
Y / Y EPS from Cont. Operations Growth (TTM) 1.72 % 2.02 % 248.4 % 246.72 % 307.6 %
Year on Year EPS from Cont. Operations Growth Overall Ranking # 699 # 898 # 94 # 108 # 27
Seqeuential EPS from Cont. Operations Change (TTM) -0.85 % -1.32 % 3.22 % 0.71 % -0.55 %
Seq. EPS from Cont. Operations Growth (TTM) Overall Ranking # 779 # 1037 # 760 # 1138 # 1191




Cumulative EPS from Cont. Operations growth Comment
With the quarterly EPS from Cont. Operations reported in the Mar 31 2020 period, Amgen Inc 's cumulative twelve months EPS from Cont. Operations were $ 13 , company would post below average annual EPS from Cont. Operations growth of -0.55% year on year, if the fiscal year would end at Mar 31 2020.
A slow-down in the Amgen Inc 's EPS from Cont. Operations growth from the 2.88% growth in Dec 31 2019.

In the Healthcare sector 61 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 699, from total ranking in previous quarter at 898.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
236.99 %
6.09 %
-76.3 %
 

EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 12
Healthcare Sector # 62
Overall # 699

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
381.31 %
29.12 %
-74.44 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 76
S&P 500 # 779
Cumulative EPS from Cont. Operations growth Comment
With the quarterly EPS from Cont. Operations reported in the Mar 31 2020 period, Amgen Inc 's cumulative twelve months EPS from Cont. Operations were $ 13 , company would post below average annual EPS from Cont. Operations growth of -74.44% year on year, if the fiscal year would end at Mar 31 2020.
A slow-down in the Amgen Inc 's EPS from Cont. Operations growth from the 2.88% growth in Dec 31 2019.

In the Healthcare sector 61 other companies have achieved higher trailing twelve month EPS from Cont. Operations growth. While Total ranking has impoved so far to 699, from total ranking in previous quarter at 898.

EPS from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
236.99 %
6.09 %
-76.3 %
 


EPS from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 12
Healthcare Sector # 62
Overall # 699

EPS from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
381.31 %
29.12 %
-74.44 %
 


EPS from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 12
Sector # 76
S&P 500 # 779




Other EPS from Cont. Operations Growth
Biotechnology & Drugs Industry EPS from Cont. Operations Growth Trends and Statistics
Healthcare Sector EPS from Cont. Operations Growth Statistics
EPS from Cont. Operations Growth Trends for overall market
AMGN's EPS from Cont. Operations Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS from Cont. Operations Growth
Lowest Ranking EPS from Cont. Operations Growth
EPS from Cont. Operations Growth for AMGN's Competitors
EPS from Cont. Operations Growth for Amgen Inc 's Suppliers
EPS from Cont. Operations Growth for AMGN's Customers

You may also want to know
AMGN's Annual Growth Rates AMGN's Profitability Ratios AMGN's Asset Turnover Ratio AMGN's Dividend Growth
AMGN's Roe AMGN's Valuation Ratios AMGN's Financial Strength Ratios AMGN's Dividend Payout Ratio
AMGN's Roa AMGN's Inventory Turnover Ratio AMGN's Growth Rates AMGN's Dividend Comparisons



Companies with similar EPS from Cont. Operations increase for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %EPS from Cont. Operations for the quarter ending Mar 31 2020
Amgen Inc -3.44 %$ -3.438 
Alexion Pharmaceuticals Inc -4.18 %$ -4.183 
Pra Health Sciences Inc -4.41 %$ -4.412 
Baxter International Inc -4.41 %$ -4.412 
Hill rom Holdings Inc -5.41 %$ -5.405 
Atrion Corp -5.70 %$ -5.697 
Mettler Toledo International Inc -9.33 %$ -9.333 
Charles River Laboratories International inc -9.65 %$ -9.649 
Phibro Animal Health Corp -10.81 %$ -10.811 
Lemaitre Vascular Inc -11.11 %$ -11.111 
Pfizer Inc -11.59 %$ -11.594 
Iradimed Corporation -11.76 %$ -11.765 
Haemonetics Corporation -14.29 %$ -14.286 
Encompass Health Corporation -16.19 %$ -16.190 
Abbott Laboratories -18.42 %$ -18.421 
Bio techne Corp -19.49 %$ -19.492 
Gilead Sciences Inc -20.65 %$ -20.645 
Bio rad Laboratories Inc -20.87 %$ -20.875 
Illumina Inc -25.32 %$ -25.316 
Universal Health Services Inc -36.19 %$ -36.187 
Quest Diagnostics Inc -39.34 %$ -39.344 
Biotelemetry Inc -40.00 %$ -40.000 
Hca Healthcare Inc -43.23 %$ -43.234 
Nuvasive Inc -44.44 %$ -44.444 
National Vision Holdings Inc -45.45 %$ -45.455 
Icu Medical Inc -46.36 %$ -46.358 
U S Physical Therapy Inc -48.72 %$ -48.718 
Abiomed Inc -56.96 %$ -56.960 
Bruker Corporation -65.00 %$ -65.000 
Fonar Corp -67.21 %$ -67.213 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FLEX's Profile

Stock Price

FLEX's Financials

Business Description

Fundamentals

Charts & Quotes

FLEX's News

Suppliers

FLEX's Competitors

Customers & Markets

Economic Indicators

FLEX's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071